Skip to main content
CMG Pharmaceutical Co., Ltd. logo

CMG Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 058820 ISIN · KR7058820002 KO Manufacturing
Open in API
Filings indexed 165 across all filing types
Latest filing 2021-03-10 AGM Information
Country KR South Korea
Listing KO 058820

About CMG Pharmaceutical Co., Ltd.

http://www.cmgpharma.co.kr

CMG Pharmaceutical Co., Ltd. is a pharmaceutical company specializing in the development of advanced drug delivery systems. The company's core competency is its Oral Thin Film (OTF), or Orally Dissolving Film (ODF), technology platform. This technology is used to develop improved new drugs, new formulations, and combination therapies designed to enhance patient convenience and efficacy. The company's portfolio includes prescription medications and general pharmaceuticals. As an affiliate of CHA Health Systems, CMG Pharmaceutical is actively engaged in research and development, managing a pipeline of drug candidates and conducting clinical trials.

Recent filings

Filing Released Lang Actions
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted by CMG Pharmaceutical regarding the scheduling of its Annual General Meeting (AGM) on a 'concentrated date' (a date when many companies hold their AGMs). It explains the internal and external reasons for choosing this date and acknowledges the KOSDAQ Association's guidelines. Since this is a regulatory notification regarding meeting logistics rather than the meeting materials themselves or the voting results, it falls under the general regulatory filing category.
2021-03-10 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for CMG Pharmaceutical. It contains the meeting agenda, details on voting procedures, and management information, which are standard components of proxy materials sent to shareholders to solicit votes for an upcoming AGM. According to the provided definitions, this fits the 'Proxy Solicitation & Information Statement' (PSI) category.
2021-03-10 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document), which is a standard regulatory filing in South Korea used to solicit proxies from shareholders for an upcoming Annual General Meeting (AGM). It contains information about the meeting date, agenda items (such as approval of financial statements), and instructions for shareholders to exercise their voting rights. This falls under the 'Proxy Solicitation & Information Statement' category.
2021-03-10 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from CMG Pharmaceutical regarding a significant change (over 30%) in sales or profit structure. It provides a summary of financial performance (revenue, operating profit, net income) compared to the previous year, along with the reasons for the change (R&D investment, foreign exchange losses). This is a standard 'Earnings Release' or 'Preliminary Financial Results' announcement required by stock exchanges when financial metrics fluctuate significantly, fitting the 'ER' category. FY 2020
2021-02-09 Korean
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for CMG Pharmaceutical, covering the period from January 1, 2020, to September 30, 2020. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2020
2020-11-12 Korean
반기보고서 (2020.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for CMG Pharmaceutical, covering the period from January 1, 2020, to June 30, 2020. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2020
2020-08-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.